Optimization of biological therapy selection in rheumatoid arthritis: insights into anemia and interleukin-6 pathway.
作者信息
Nam Bora
机构信息
Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea.
出版信息
J Rheum Dis. 2025 Jan 1;32(1):1-2. doi: 10.4078/jrd.2024.0133. Epub 2024 Dec 13.
Abstract
摘要
相似文献
1
Optimization of biological therapy selection in rheumatoid arthritis: insights into anemia and interleukin-6 pathway.类风湿关节炎生物治疗选择的优化：对贫血和白细胞介素-6通路的见解
J Rheum Dis. 2025 Jan 1;32(1):1-2. doi: 10.4078/jrd.2024.0133. Epub 2024 Dec 13.
2
Erythropoiesis-stimulating agents for anemia in rheumatoid arthritis.用于类风湿关节炎贫血的促红细胞生成素
Cochrane Database Syst Rev. 2013 Feb 28;2013(2):CD000332. doi: 10.1002/14651858.CD000332.pub3.
3
Telmisartan alone or in combination with etanercept improves anemia associated with rheumatoid arthritis in rats: a possible role of anti-inflammatory and reno-protective effects.替米沙坦单独或与依那西普联合使用可改善类风湿关节炎相关贫血：可能具有抗炎和肾保护作用。
Pharmacol Rep. 2020 Apr;72(2):379-388. doi: 10.1007/s43440-019-00033-w. Epub 2020 Jan 8.
4
Decreased expression of integrins by hematopoietic cells in patients with rheumatoid arthritis and anemia: relationship with bone marrow cytokine levels.类风湿关节炎和贫血患者造血细胞中整合素表达降低：与骨髓细胞因子水平的关系。
J Investig Allergol Clin Immunol. 2008;18(1):17-21.
5
Mechanism of anaemia in rheumatoid arthritis: demonstration of raised interleukin 1 beta concentrations in anaemic patients and of interleukin 1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukaemia (HEL) cells in vitro.类风湿关节炎贫血的机制：贫血患者白细胞介素1β浓度升高以及白细胞介素1在体外介导对正常红细胞生成和人红白血病（HEL）细胞增殖的抑制作用的证明。
Ann Rheum Dis. 1988 Dec;47(12):972-8. doi: 10.1136/ard.47.12.972.
6
Role of interleukin-6 in the anemia of chronic disease.白细胞介素-6在慢性病贫血中的作用。
Semin Arthritis Rheum. 2009 Apr;38(5):382-8. doi: 10.1016/j.semarthrit.2008.01.006. Epub 2008 Mar 12.
7
8
Circulating hepcidin in the crossroads of anemia and inflammation associated with rheumatoid arthritis.循环中的铁调素处于类风湿关节炎相关贫血与炎症的交叉点。
Intern Med. 2009;48(6):421-6. doi: 10.2169/internalmedicine.48.1578. Epub 2009 Mar 16.
9
Development of rheumatoid arthritis in a patient with pernicious anemia: case report.恶性贫血患者并发类风湿关节炎：病例报告
Chang Gung Med J. 2001 Feb;24(2):125-9.
10
A towards-multidimensional screening approach to predict candidate genes of rheumatoid arthritis based on SNP, structural and functional annotations.基于 SNP、结构和功能注释的类风湿关节炎候选基因的多维筛选方法。
BMC Med Genomics. 2010 Aug 20;3:38. doi: 10.1186/1755-8794-3-38.
本文引用的文献
1
Anemia as an indicator of a higher retention rate for tocilizumab versus tumor necrosis factor inhibitors in patients with rheumatoid arthritis from a Korean multi-center registry.在韩国一项多中心登记研究中，贫血作为类风湿关节炎患者使用托珠单抗比使用肿瘤坏死因子抑制剂保留率更高的一个指标。
J Rheum Dis. 2024 Oct 1;31(4):212-222. doi: 10.4078/jrd.2024.0026. Epub 2024 Jun 14.
2
Therapeutic advances in rheumatoid arthritis.类风湿关节炎的治疗进展。
BMJ. 2024 Jan 17;384:e070856. doi: 10.1136/bmj-2022-070856.
3
KOBIO, the First Web-based Korean Biologics Registry Operated With a Unified Platform Among Distinct Disease Entities.KOBIO，首个基于网络的韩国生物制品注册库，在不同疾病实体间通过统一平台运行。
J Rheum Dis. 2021 Oct 1;28(4):176-182. doi: 10.4078/jrd.2021.28.4.176.
4
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.EULAR 推荐的类风湿关节炎治疗方案：使用合成和生物疾病修正抗风湿药物：2022 更新版。
Ann Rheum Dis. 2023 Jan;82(1):3-18. doi: 10.1136/ard-2022-223356. Epub 2022 Nov 10.
5
Medication adherence and persistence in patients with autoimmune rheumatic diseases: a narrative review.自身免疫性风湿疾病患者的药物依从性和持续性：一篇叙述性综述
Patient Prefer Adherence. 2018 Jul 3;12:1151-1166. doi: 10.2147/PPA.S165101. eCollection 2018.
6
Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study.利妥昔单抗对比另一种肿瘤坏死因子抑制剂用于对既往单一肿瘤坏死因子抑制剂治疗无反应的类风湿关节炎患者：SWITCH-RA，一项全球、观察性、比较疗效研究。
Ann Rheum Dis. 2015 Jun;74(6):979-84. doi: 10.1136/annrheumdis-2013-203993. Epub 2014 Jan 17.
7
Role of interleukin-6 in the anemia of chronic disease.白细胞介素-6在慢性病贫血中的作用。
Semin Arthritis Rheum. 2009 Apr;38(5):382-8. doi: 10.1016/j.semarthrit.2008.01.006. Epub 2008 Mar 12.
8
Anemia in early rheumatoid arthritis is associated with interleukin 6-mediated bone marrow suppression, but has no effect on disease course or mortality.早期类风湿性关节炎中的贫血与白细胞介素6介导的骨髓抑制有关，但对疾病进程或死亡率无影响。
J Rheumatol. 2008 Mar;35(3):380-6. Epub 2008 Feb 1.
9
Interleukin-6 is a potent thrombopoietic factor in vivo in mice.白细胞介素-6是小鼠体内一种有效的血小板生成因子。
Blood. 1989 Sep;74(4):1241-4.
10
Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes.白细胞介素-6是成人肝细胞中急性期蛋白合成的主要调节因子。
FEBS Lett. 1989 Jan 2;242(2):237-9. doi: 10.1016/0014-5793(89)80476-4.
Zotero 插件